progabide has been researched along with valproate sodium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howard, HR; Koe, BK; Sarges, R; Weissman, A | 1 |
| Bartholini, G; Desarmenien, M; Feltz, P; Headley, PM; Kaplan, JP; Lloyd, KG; Raizon, BM; Worms, P | 1 |
2 other study(ies) available for progabide and valproate sodium
| Article | Year |
|---|---|
A novel class of "GABAergic" agents: 1-aryl-3-(aminoalkylidene)oxindoles.
Topics: 3-Mercaptopropionic Acid; Animals; Flunitrazepam; Indoles; Male; Mice; Receptors, GABA-A; Structure-Activity Relationship; Sulfhydryl Compounds | 1989 |
New anticonvulsants: Schiff bases of gamma-aminobutyric acid and gamma-aminobutyramide.
Topics: Animals; Anticonvulsants; Bicuculline; Brain; Cerebellum; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Ganglia, Spinal; Humans; In Vitro Techniques; Lethal Dose 50; Male; Mice; Rats; Schiff Bases | 1980 |